Isabel Gomila

Isabel Gomila

Auto-generated profile, based on publicly available information

Isabel Gomila

Clinical Analysis Department, Son Llàtzer University Hospital, 07198 Palma de Mallorca, Spain

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Forensic Science International
Verified
Journal Article
Closed access
BBBernardino Barcelò
Bernardino Barcelò
SPSimona Pichini
Simona Pichini
VLVictoria López-Corominas
Victoria López-Corominas
IGIsabel Gomila
Isabel Gomila
CYChristopher Yates
Christopher Yates
MPManuela Pellegrini
Manuela Pellegrini

19 May 2011 in Urological Research
Verified
Journal Article
Closed access
PDF file
FGFelix Grases
Felix Grases
ACAntonia Costa-Bauza
Antonia Costa-Bauza
IGI. Gomila
I. Gomila
MRM. Ramis
M. Ramis
AGA. García-Raja
A. García-Raja
RPRafel M. Prieto
Rafel M. Prieto

10 December 2008 in Urological Research
Verified
Journal Article
Closed access
PDF file
FGFelix Grases
Felix Grases
RPRafel M. Prieto
Rafel M. Prieto
IGIsabel Gomila
Isabel Gomila
PSPilar Sanchis
Pilar Sanchis
ACAntonia Costa-Bauza
Antonia Costa-Bauza

15 July 2017 in International journal of legal medicine
Verified
Journal Article
Closed access
PDF file
BBBernardino Barcelò
Bernardino Barcelò
IGIsabel Gomila
Isabel Gomila
MRMaria Concetta Rotolo
Maria Concetta Rotolo
EMEmilia Marchei
Emilia Marchei
CKChrystalla Kyriakou
Chrystalla Kyriakou
Francesco P. Busardó Francesco P. Busardó
Francesco P. Busardó

1 October 2011 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
EAEmilia Amengual-Cladera
Emilia Amengual-Cladera
ANAntònia Nadal-Casellas
Antònia Nadal-Casellas
YGYolanda Gómez-Pérez
Yolanda Gómez-Pérez
IGIsabel Gomila
Isabel Gomila
RPRafel M. Prieto
Rafel M. Prieto
ILIsabel Lladó
Isabel Lladó
Serum paraoxonase 1 (PON1) has been reported to be an important contributor to the antioxidant and anti-inflammatory activities of HDL, avoiding LDL oxidation. The activity of this enzyme is reduced in patients with renal insufficiency, caused by elevated oxidative stress and disturbances of apolipoprotein metabolism. Therapeutic utilization of antioxidants to control renal oxidative stress may be an effective therapy in renal protection. The aim was to investigate the protective effects of several antioxidant compounds against the oxidative stress associated to renal failure induced by ethylene glycol (EG), focusing on the possible role of serum PON1 activity. Fifty-four male Wistar rats were randomly assigned to six groups (n = 9): an untreated control (C) group, an EG-treated group, a catechin (CAT)-treated group, an epicatechin (EPI)-treated group, a quercetin (QUE)-treated group and a folk herbal extract (FHE)-treated group. After 16 d of treatment, calcium oxalate lithiasis was induced in the rats using EG. After eight days (treatment + EG), the animals were sacrificed. EG treatment impaired kidney composition, increased oxidative damage, and decreased serum paraoxonase and arylesterase activities. CAT, QUE and the FHE Fagolitos improved oxidative status by enhancing antioxidant defenses – superoxide dismutase and PON1 activities – and reducing oxidative damage, thus reinforcing the idea of a possible role of PON1 in the protective effects of QUE against the deleterious consequences of oxidative stress in kidney.

1 June 2009 in Urology
Verified
Journal Article
Closed access
FGFelix Grases
Felix Grases
ACAntonia Costa-Bauza
Antonia Costa-Bauza
IGI. Gomila
I. Gomila
SSS. Serra-Trespalle
S. Serra-Trespalle
FAF. Alonso-Sainz
F. Alonso-Sainz
JVJ.M. del Valle
J.M. del Valle